-
Amblard F, Delinsky D, Arbiser JL, Schinazi RF, 2006: Facile purification of honokiol and its antiviral and cytotoxic properties[J]. J Med Chem, 49, 3426-3427. doi: 10.1021/jm060268m
-
Andrei G, Topalis D, Fiten P, McGuigan C, Balzarini J, Opdenakker G, Snoeck R, 2012: In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs[J]. J Virol, 86, 2641-2652. doi: 10.1128/JVI.06620-11
-
Averett C, Bhardwaj A, Arora S, Srivastava SK, Khan MA, Ahmad A, Singh S, Carter JE, Khushman M, Singh AP, 2016: Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk[J]. Carcinogenesis, 37, 1052-1061. doi: 10.1093/carcin/bgw096
-
Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL, 2003: Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo[J]. J Biol Chem, 278, 35501-35507. doi: 10.1074/jbc.M302967200
-
Balfour HH Jr, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S, 1994: Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections[J]. J Acquir Immune Defic Syndr, 7, 254-260.
-
Bang KH, Kim YK, Min BS, Na MK, Rhee YH, Lee JP, Bae KH, 2000: Antifungal activity of magnolol and honokiol[J]. Arch Pharm Res, 23, 46-49. doi: 10.1007/BF02976465
-
Darling AJ, Boose JA, Spaltro J, 1998: Virus assay methods: accuracy and validation[J]. Biologicals, 26, 105-110. doi: 10.1006/biol.1998.0134
-
Elion GB, 1993: Acyclovir: discovery, mechanism of action, and selectivity[J]. J Med Virol Suppl, 1, 2-6.
-
Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ, 1977: Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine[J]. Proc Natl Acad Sci U S A, 74, 5716-5720. doi: 10.1073/pnas.74.12.5716
-
Fang CY, Chen SJ, Wu HN, Ping YH, Lin CY, Shiuan D, Chen CL, Lee YR, Huang KJ, 2015: Honokiol, a lignan biphenol derived from the magnolia tree, inhibits dengue virus type 2 infection[J]. Viruses, 7, 4894-4910. doi: 10.3390/v7092852
-
Field HJ, Vere Hodge RA, 2013: Recent developments in antiherpesvirus drugs[J]. Br Med Bull, 106, 213-249. doi: 10.1093/bmb/ldt011
-
Fried LE, Arbiser JL, 2009: Honokiol, a multifunctional antiangiogenic and antitumor agent[J]. Antioxid Redox Signal, 11, 1139-1148. doi: 10.1089/ars.2009.2440
-
Hafidh RR, Abdulamir AS, Abu Bakar F, Sekawi Z, Jahansheri F, Jalilian FA, 2015: Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines[J]. BMC Complement Altern Med, 15, 179-. doi: 10.1186/s12906-015-0688-2
-
Jacobo-Salcedo Mdel R, Gonzalez-Espindola LA, Alonso-Castro AJ, Gonzalez-Martinez Mdel R, Dominguez F, Garcia-Carranca A, 2011: Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds[J]. Nat Prod Commun, 6, 1121-1124.
-
Jin J, Guo N, Zhang J, Ding Y, Tang X, Liang J, Li L, Deng X, Yu L, 2010: The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans[J]. Lett Appl Microbiol, 51, 351-357. doi: 10.1111/lam.2010.51.issue-3
-
Kumar A, Kumar Singh U, Chaudhary A, 2013: Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities[J]. Future Med Chem, 5, 809-829. doi: 10.4155/fmc.13.32
-
Kuribara H, Stavinoha WB, Maruyama Y, 1999: Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam-like side-effects in mice[J]. J Pharm Pharmacol, 51, 97-103.
-
Kuribara H, Kishi E, Hattori N, Okada M, Maruyama Y, 2000: The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark[J]. J Pharm Pharmacol, 52, 1425-1429. doi: 10.1111/(ISSN)2042-7158
-
Lan KH, Wang YW, Lee WP, Lan KL, Tseng SH, Hung LR, Yen SH, Lin HC, Lee SD, 2012: Multiple effects of Honokiol on the life cycle of hepatitis C virus[J]. Liver Int, 32, 989-997. doi: 10.1111/liv.2012.32.issue-6
-
Leary JJ, Wittrock R, Sarisky RT, Weinberg A, Levin MJ, 2002: Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines[J]. Antimicrob Agents Chemother, 46, 762-768. doi: 10.1128/AAC.46.3.762-768.2002
-
Li Y, Wang S, Zhu H, Zheng C, 2011: Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome[J]. Arch Virol, 156, 2267-2272. doi: 10.1007/s00705-011-1094-9
-
Li WL, Zhao XC, Zhao ZW, Huang YJ, Zhu XZ, Meng RZ, Shi C, Yu L, Guo N, 2016: In vitro antimicrobial activity of honokiol against Staphylococcus aureus in biofilm mode[J]. J Asian Nat Prod Res, 18, 1178-1185. doi: 10.1080/10286020.2016.1194829
-
Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK, 2003: The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production[J]. Eur J Pharmacol, 475, 19-27. doi: 10.1016/S0014-2999(03)02121-6
-
Maruyama Y, Kuribara H, Morita M, Yuzurihara M, Weintraub ST, 1998: Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine[J]. J Nat Prod, 61, 135-138. doi: 10.1021/np9702446
-
Pan J, Zhang Q, Liu Q, Komas SM, Kalyanaraman B, Lubet RA, Wang Y, You M, 2014: Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function[J]. Cancer Prev Res (Phila), 7, 1149-1159. doi: 10.1158/1940-6207.CAPR-14-0091
-
Park J, Lee J, Jung E, Park Y, Kim K, Park B, Jung K, Park E, Kim J, Park D, 2004: In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp[J]. Eur J Pharmacol, 496, 189-195. doi: 10.1016/j.ejphar.2004.05.047
-
Reusser P, 1996: Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options[J]. J Hosp Infect, 33, 235-248.
-
Sakaue Y, Domon H, Oda M, Takenaka S, Kubo M, Fukuyama Y, Okiji T, Terao Y, 2016: Anti-biofilm and bactericidal effects of magnolia bark-derived magnolol and honokiol on Streptococcus mutans[J]. Microbiol Immunol, 60, 10-16. doi: 10.1111/1348-0421.12343
-
Sato Y, Kato A, Maruzuru Y, Oyama M, Kozuka-Hata H, Arii J, Kawaguchi Y, 2016: Cellular transcriptional coactivator RanBP10 and herpes simplex virus 1 ICP0 interact and synergistically promote viral gene expression and replication[J]. J Virol, 90, 3173-3186. doi: 10.1128/JVI.03043-15
-
Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW, 2007: Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells[J]. Cancer, 109, 1279-1289. doi: 10.1002/(ISSN)1097-0142
-
Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F, 2016: Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors[J]. Oncotarget, 7, 57752-57769.
-
Tan EL, Ooi EE, Lin CY, Tan HC, Ling AE, Lim B, Stanton LW, 2004: Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs[J]. Emerg Infect Dis, 10, 581-586. doi: 10.3201/eid1004.030458
-
Tan L, Zhang C, Dematos J, Kuang L, Jung JU, Liang X, 2016: CD95 signaling inhibits B cell receptor-mediated gammaherpesviral replication in apoptosis-resistant B lymphoma cells[J]. J Virol, 90, 9782-9796. doi: 10.1128/JVI.00668-16
-
Tian W, Xu D, Deng YC, 2012: Honokiol, a multifunctional tumor cell death inducer[J]. Pharmazie, 67, 811-816.
-
Wolf I, O'Kelly J, Wakimoto N, Nguyen A, Amblard F, Karlan BY, Arbiser JL, Koeffler HP, 2007: Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest[J]. Int J Oncol, 30, 1529-1537.
-
Woodbury A, Yu SP, Wei L, Garcia P, 2013: Neuro-modulating effects of honokiol: a review[J]. Front Neurol, 4, 130-.
-
Wutzler P, 1997: Antiviral therapy of herpes simplex and varicella-zoster virus infections[J]. Intervirology, 40, 343-356. doi: 10.1159/000150567
-
Xu HL, Tang W, Du GH, Kokudo N, 2011: Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis[J]. Drug Discov Ther, 5, 202-210. doi: 10.5582/ddt.2011.v5.5.202
-
Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J, 2015: Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis[J]. Oncotarget, 6, 37335-37348.